Ledger.Open graph →
SEC Form D · filed March 28, 2018

Wallkill BioPharma Inc

Offering
$208K
Sold
$208K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Martin Bell · NEW YORK, NYExec · DirectorGerald Swiss · RANCHO SANTA FE, CAExec · DirectorGerald Swiss · RANCHO SANTA FE, CAExec · DirectorMartin Bell · Westport, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗